Reliability and Validity of the Adolescent Idiopathic Scoliosis - Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ)

NCT ID: NCT07276165

Last Updated: 2025-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2026-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey examines how individuals with scoliosis define themselves and their physical appearance. Our aim in this study was to translate this survey into Turkish and demonstrate its reliability and validity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The "Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire" was developed to investigate how individuals with scoliosis feel about their frontal body appearance. The survey was developed by BS Lonner and colleagues and published in 2023. It consists of 14 questions. Female patients with scoliosis are asked to answer these questions personally. Permission for the Turkish validity and reliability of the survey was requested and received on November 18, 2024. The survey questions how individuals with scoliosis define themselves and their physical perception of their bodies. The aim of this study is to translate this survey into Turkish and demonstrate its reliability and validity. This study will examine the test-retest reliability and internal consistency of the Adolescent Idiopathic Scoliosis-Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ), and its validity with the SRS-22 and Walter Reed questionnaires. This study was designed as an intra-rater and intra-rater reliability and structural validity study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scoliosis Idiopathic Adolescent Scoliosis Define Themselves Physical Perception of Their Bodies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scoliosis Group

The study sample consists of female individuals between the ages of 10-18 diagnosed with adolescent idiopathic scoliosis.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescent idiopathic diagnosis

Exclusion Criteria

* Individuals who did not agree to participate in the study
Minimum Eligible Age

10 Years

Maximum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hasan Kalyoncu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tuğba GÖNEN

Assist. Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tuğba GÖNEN, Asisst. Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Hasan Kalyoncu University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasan Kalyoncu University

Gaziantep, Gaziantep, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tuğba GÖNEN, Asisst. Prof. Dr.

Role: CONTACT

505 090 58 46

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tuğba GÖNEN, Asisst. Prof. Dr.

Role: primary

505 090 58 46

References

Explore related publications, articles, or registry entries linked to this study.

Alanay A, Cil A, Berk H, Acaroglu RE, Yazici M, Akcali O, Kosay C, Genc Y, Surat A. Reliability and validity of adapted Turkish Version of Scoliosis Research Society-22 (SRS-22) questionnaire. Spine (Phila Pa 1976). 2005 Nov 1;30(21):2464-8. doi: 10.1097/01.brs.0000184366.71761.84.

Reference Type RESULT
PMID: 16261127 (View on PubMed)

Asher M, Min Lai S, Burton D, Manna B. The reliability and concurrent validity of the scoliosis research society-22 patient questionnaire for idiopathic scoliosis. Spine (Phila Pa 1976). 2003 Jan 1;28(1):63-9. doi: 10.1097/00007632-200301010-00015.

Reference Type RESULT
PMID: 12544958 (View on PubMed)

Sanders JO, Polly DW Jr, Cats-Baril W, Jones J, Lenke LG, O'Brien MF, Stephens Richards B, Sucato DJ; AIS Section of the Spinal Deformity Study Group. Analysis of patient and parent assessment of deformity in idiopathic scoliosis using the Walter Reed Visual Assessment Scale. Spine (Phila Pa 1976). 2003 Sep 15;28(18):2158-63. doi: 10.1097/01.BRS.0000084629.97042.0B.

Reference Type RESULT
PMID: 14501929 (View on PubMed)

Alhada TL, Castel LC, Pfirrmann C, Davoust L, Loot M, Angelliaume A, Harper L, Lefevre Y. Translation and validation of the French version of the adolescent idiopathic scoliosis Truncal Anterior Asymmetry Scoliosis Questionnaire (TAASQ). Spine Deform. 2023 Nov;11(6):1363-1369. doi: 10.1007/s43390-023-00736-4. Epub 2023 Aug 2.

Reference Type RESULT
PMID: 37531015 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/49

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.